BIOSENSE/CORDIS CARTO 3-D CARDIAC MAPPING TECHNOLOGY SLATED TO ENTER CLINICALS FOR ABLATION PROCEDURES; IDE APPLICATION UNDER REVIEW BY FDA

More from Archive

More from Medtech Insight